Orosomucoid (ORM) as a Potential Biomarker for the Diagnosis of Chronic Fatigue Syndrome (CFS)

CNS Neurosci Ther. 2016 Mar;22(3):251-2. doi: 10.1111/cns.12522. Epub 2016 Feb 2.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood*
  • Fatigue Syndrome, Chronic / blood*
  • Fatigue Syndrome, Chronic / diagnosis*
  • Female
  • Glucocorticoids / blood
  • Glucocorticoids / cerebrospinal fluid
  • Humans
  • Hydrocortisone / blood
  • Male
  • Orosomucoid / metabolism*

Substances

  • Biomarkers
  • Glucocorticoids
  • Orosomucoid
  • Hydrocortisone